DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.
Heethuis SE, Goense L, van Rossum PSN, Borggreve AS, Mook S, Voncken FEM, Bartels-Rutten A, Aleman BMP, van Hillegersberg R, Ruurda JP, Meijer GJ, Lagendijk JJW, van Lier ALHMW.
Heethuis SE, et al. Among authors: aleman bmp.
Acta Oncol. 2018 Sep;57(9):1201-1208. doi: 10.1080/0284186X.2018.1473637. Epub 2018 May 21.
Acta Oncol. 2018.
PMID: 29781342
Clinical Trial.